TheBioTechReview

Industry Radar

Exploring the latest in Industry Radar.

Beyond Survival: How RMC-6236's KRAS G12D Breakthrough Reshapes the Pancreatic Cancer Market and Investment Landscape
Industry Radar

Beyond Survival: How RMC-6236's KRAS G12D Breakthrough Reshapes the Pancreatic Cancer Market and Investment Landscape

Allogene's Off-the-Shelf CAR-T Data: A Turning Point for Manufacturing and Access in Lymphoma?
Industry Radar

Allogene's Off-the-Shelf CAR-T Data: A Turning Point for Manufacturing and Access in Lymphoma?

Beyond the Headlines: How ACIP Rule Changes and Protein Degrader R&D Reveal a Biopharma Industry at a Crossroads
Industry Radar

Beyond the Headlines: How ACIP Rule Changes and Protein Degrader R&D Reveal a Biopharma Industry at a Crossroads

Beyond the Megaround: How Oricell's Pre-IPO Bet Exposes the Next Frontier in the CAR-T Arms Race
Industry Radar

Beyond the Megaround: How Oricell's Pre-IPO Bet Exposes the Next Frontier in the CAR-T Arms Race

Beyond the IPO: How Avalyn Pharma's Inhaled IPF Strategy Challenges a $4 Billion Market
Industry Radar

Beyond the IPO: How Avalyn Pharma's Inhaled IPF Strategy Challenges a $4 Billion Market

Beyond the Headlines: The Hidden Market Logic Behind Pharma's Pricing, Trials & Unlikely Alliances
Industry Radar

Beyond the Headlines: The Hidden Market Logic Behind Pharma's Pricing, Trials & Unlikely Alliances